logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

HANXBIO-B (03378) spent 631,200 Hong Kong dollars to repurchase 22,400 shares on May 27th.

date
18:56 27/05/2026
avatar
GMT Eight
Hanergy Thin Film Power Group Limited (03378) issued an announcement on May 27, 2026 that the company repurchased 22,400 shares for a total amount of HK$631,200, at a repurchase price of HK$27.52-29.48 per share.
HANXBIO-B(03378) announced that on May 27, 2026, the company spent HK$631,200 to repurchase 22,400 shares at a repurchase price of HK$27.52-29.48 per share.
Related Articles
HK Stock
Pharmaron Beijing (03759) plans to build a project in Shaoxing that would produce 200 tons of pharmaceutical intermediates and APIs annually.
HK Stock
CONSUN PHARMA (01681) plans to carry out a share buyback program.
HK Stock
Pharmaron Beijing (03759) plans to invest approximately 2 billion yuan to establish a new drug commercial production and CDMO research and development production service base in Qiantang District, Hangzhou City.
Pharmaron Beijing (03759) plans to build a project in Shaoxing that would produce 200 tons of pharmaceutical intermediates and APIs annually.
HK Stock
CONSUN PHARMA (01681) plans to carry out a share buyback program.
HK Stock
Pharmaron Beijing (03759) plans to invest approximately 2 billion yuan to establish a new drug commercial production and CDMO research and development production service base in Qiantang District, Hangzhou City.
HK Stock
RECOMMEND
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
icon
21/05/2026
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
icon
21/05/2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
icon
21/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.